{
  "completed": true,
  "status": "documented_historical_discovery_and_reconciliation",
  "provider": "Consensus",
  "provider_mode": "Historical browser/connector use as recorded in the source artifacts",
  "local_audit_date": "2026-10-09",
  "primary_comparison_count": null,
  "reported_usage": [],
  "grade_changed": false,
  "score_before": {
    "hsef_level": "Γ",
    "hsef_descriptor": "Mechanistically plausible, partial system support",
    "confidence": "Moderate",
    "confidence_rationale": "69 primary reports with 6 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "The preregistered scope-matched gate SC5 yields Γ. Defined experimental lineage and tumour-control sensitivities reach Ζ; clinical checkpoint efficacy alone can reach Η in selected indications, but neither establishes terminal-state mediation or cross-solid-tumour dominance. The weakest-link bundle would be Β because of the observational existence subclaim; it is not the registered gate."
  },
  "score_after": {
    "hsef_level": "Γ",
    "hsef_descriptor": "Mechanistically plausible, partial system support",
    "confidence": "Moderate",
    "confidence_rationale": "69 primary reports with 6 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "The preregistered scope-matched gate SC5 yields Γ. Defined experimental lineage and tumour-control sensitivities reach Ζ; clinical checkpoint efficacy alone can reach Η in selected indications, but neither establishes terminal-state mediation or cross-solid-tumour dominance. The weakest-link bundle would be Β because of the observational existence subclaim; it is not the registered gate."
  },
  "independent_blinded_audit": false,
  "raw_receipts": [
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\checkpoint-exhaustion-tumor-evasion\\consensus\\browser-proof.png",
      "sha256": "6e19a068d3666b6f3c6342f887eb378b1e398786d4597593f0ad5be379e363e3"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\checkpoint-exhaustion-tumor-evasion\\consensus\\deep-dom.txt",
      "sha256": "b8c8f81e306992a23d0d6a9194c142238572003f135621b4b4caba16c9a0c046"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\checkpoint-exhaustion-tumor-evasion\\consensus\\deep-response.txt",
      "sha256": "9c09fe1dad85eea7f70478f5697f0cf40bf414e990786cb418e22dea76ce9c0b"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\checkpoint-exhaustion-tumor-evasion\\consensus\\pro-dom.txt",
      "sha256": "deda34080d804a874bf182d0bc18141afc30804e1011babdd080f74c5b890c0a"
    },
    {
      "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\checkpoint-exhaustion-tumor-evasion\\consensus\\pro-response.txt",
      "sha256": "2f0747a255917bca2ede727f507a7bec41e5b054949ceabf78988c66409efc54"
    }
  ],
  "limitations": "This verifies documented historical use and links the record to the final edition. It adds no primary-source, full-text, independence or verification credit. Original access remains limited to the source-specific record."
}